A view on drug resistance in cancer

N Vasan, J Baselga, DM Hyman - Nature, 2019 - nature.com
The problem of resistance to therapy in cancer is multifaceted. Here we take a reductionist
approach to define and separate the key determinants of drug resistance, which include …

The functional roles of the circRNA/Wnt axis in cancer

C Xue, G Li, Q Zheng, X Gu, Z Bao, J Lu, L Li - Molecular Cancer, 2022 - Springer
CircRNAs, covalently closed noncoding RNAs, are widely expressed in a wide range of
species ranging from viruses to plants to mammals. CircRNAs were enriched in the Wnt …

Cancer overdiagnosis: a biological challenge and clinical dilemma

S Srivastava, EJ Koay, AD Borowsky… - Nature Reviews …, 2019 - nature.com
For cancer screening to be successful, it should primarily detect cancers with lethal potential
or their precursors early, leading to therapy that reduces mortality and morbidity. Screening …

Cell origins of high-grade serous ovarian cancer

J Kim, EY Park, O Kim, JM Schilder, DM Coffey… - Cancers, 2018 - mdpi.com
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is
the most common and deadliest type of ovarian cancer. HGSC appears to arise from the …

Cancer screening and early detection in the 21st century

JT Loud, J Murphy - Seminars in oncology nursing, 2017 - Elsevier
Objective To review the trends in and principles of cancer screening and early detection.
Data Sources Journal articles, United States Preventive Services Task Force (USPSTF) …

The WISDOM Study: breaking the deadlock in the breast cancer screening debate

LJ Esserman - NPJ breast cancer, 2017 - nature.com
There are few medical issues that have generated as much controversy as screening for
breast cancer. In science, controversy often stimulates innovation; however, the intensely …

Cancer screening in China: the current status, challenges, and suggestions

M Cao, H Li, D Sun, S He, Y Yu, J Li, H Chen, J Shi… - Cancer Letters, 2021 - Elsevier
Substantial progress has been made in cancer screening in China due to the substantial
efforts of all levels of the government. Four large-scale population-based screening …

Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial

Y Shieh, M Eklund, L Madlensky… - Journal of the …, 2017 - academic.oup.com
Ongoing controversy over the optimal approach to breast cancer screening has led to
discordant professional society recommendations, particularly in women age 40 to 49 years …

A research ethics framework for the clinical translation of healthcare machine learning

MD McCradden, JA Anderson… - The American Journal …, 2022 - Taylor & Francis
The application of artificial intelligence and machine learning (ML) technologies in
healthcare have immense potential to improve the care of patients. While there are some …

Breast cancer risk prediction using a clinical risk model and polygenic risk score

Y Shieh, D Hu, L Ma, S Huntsman, CC Gard… - Breast cancer research …, 2016 - Springer
Breast cancer risk assessment can inform the use of screening and prevention modalities.
We investigated the performance of the Breast Cancer Surveillance Consortium (BCSC) risk …